453 results on '"Gerosa, Maria"'
Search Results
102. P75 Anti-SSA/Ro positivity and the risk of congenital heart block: obstetric and fetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases
103. O31 Integrative analysis reveals a molecular stratification of systemic autoimmune diseases
104. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases
105. Editorial: New Therapies in the Field of Rheumatology
106. INTERFERON-INDUCIBLE PROTEIN IFI16 AUTOANTIBODIES
107. LIST OF CONTRIBUTORS
108. Fetal and Obstetric Manifestations in the Antiphospholipid Syndrome
109. Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases)
110. Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository.
111. Gestione della gravidanza nelle donne con malattia di Behçet e vasculiti.
112. COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION).
113. Non-organ Specific Autoimmunity Involvement in Cardiovascular Disease
114. Update on pregnancy in autoimmune diseases
115. 5th International Conference on Sex Hormones, Pregnancy and Rheumatic Disease
116. Transforming Growth Factor β1 in the Pathogenesis of Autoimmune Congenital Complete Heart Block: Lesson From Twins and Triplets Discordant for the Disease
117. Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry
118. Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository.
119. Circulating stem cell factor in patients with chronic idiopathic urticaria
120. HYDROXYCHLOROQUINE IN PREGNANT PATIENTS WITH RHEUMATIC DISEASE: GESTATIONAL AND NEONATAL OUTCOME.
121. Diversity and somatic hypermutation of the Ig V HDJ H, VκJκ, and VλJλ Gene Segments in Lymphoma B cells: Relevance to the origin of the neoplastic B cell clone
122. Endothelium as a target for antiphospholipid antibodies
123. EEcacy, Safety, and Predictor of Response to Belimumab in a Large Nationwide Cohort Study of Patients with Active Systemic Lupus Erythematosus
124. Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies
125. FRI0569 WHAT DOES IT MEAN TO BECOME PREGNANT WITH JUVENILE IDIOPATHIC ARTHRITIS? A MONOCENTRIC EXPERIENCE IN A TERTIARY CENTRE OF MILAN DEDICATED TO YOUNG ADULTS AFFECTED BY JIA
126. FRI0186 HYDROXYCHLOROQUINE ON THE TOP OF STANDARD TREATMENT WITH LOW DOSE ASPIRIN AND LOW MOLECULAR WEIGHT HEPARIN SIGNIFICANTLY REDUCES THE PROBABILITY OF PREGNANCY MORBIDITY IN WOMEN WITH MULTIPLE POSITIVITY FOR ANTI-PHOSPHOLIPID ANTIBODIES
127. FRI0199 EFFECTIVENESS AND SAFETY OF BELIMUMAB IN PATIENTSWITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A LARGE, NATIONWIDE, MULTICENTRIC STUDY
128. OP0046 MULTICENTRIC STUDY COMPARING CYCLOSPORINE, MYCOPHENOLATE MOFETIL AND AZATHIOPRINE IN THE MAINTENANCE THERAPY OF LUPUS NEPHRITIS: 10 YEARS FOLLOW UP
129. Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome
130. Lung Disease in Antiphospholipid Syndrome
131. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases
132. First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry)
133. Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies
134. P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus
135. Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis
136. Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTIONInternational Clinical Database and Repository
137. Anti‐phospholipid antibodies and reproductive failures.
138. EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies.
139. Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
140. Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery
141. The use of biologics and small molecules in pregnant patients with rheumatic diseases
142. Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications
143. The treatment of anti-phospholipid syndrome: A comprehensive clinical approach
144. Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome
145. Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study
146. Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study
147. The Risk of Obstetric Complications and the Effects of Treatment in Women with Low Titer and Medium-High Titer Anti-Phospholipid Antibodies
148. Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study
149. β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome
150. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.